Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Gastrointestinal 1

Conditions

Obesity 1Non-alcoholic Fatty Liver Disease 1Metabolic Syndrome 1Liver Cirrhosis 1Leukemia, Myeloid, Acute 1Colorectal Neoplasms 1Cardiotoxicity 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Medical History Taking × Clear all
NCT05703126 2024-11-05

Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML

Samara State Medical University

Phase NA Recruiting
100 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Cardiotoxicity

NCT03663062 2020-11-04

OSCAR

South Tyneside and Sunderland NHS Foundation Trust

Completed
1,430 enrolled
GastrointestinalOther

Liver Cirrhosis, Obesity, Colorectal Neoplasms, Metabolic Syndrome, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡